Table 1

Characteristics of studies included in meta-analysis

First authorYearCohort designationPopulationFollow-up (years)Diabetes ascertainment*Baseline SUA (mg/dl)Age (years)% MenNumber of participantsNumber of casesCohort design
Medalie (15)1975IIHDSIsrael5.0Both4.8491008,688344H
Ohlson (16)1988SMBSweden13.5Both5.35010076647H
Perry (17)1995BRHSBritish12.8Report6.0501007,577194P
Chou (18)1998KSChina2.0Measure5.8505265439H
Taniguchi (19)2001OHSJapan9.5Measure5.2411006,478639P
Meisinger (20)2002MONIKAGermany
    Men7.6Report5.7521003,052128H
    Women4.05103,11485H
Lin (21)2004KSChina7.0Both
    Men8.04910029327H
    Women7.155016121H
Chien (22)2008CSCCCChina9.0Measure5.654432,690548H
Dehghan (23)2008RSthe Netherlands10.1Both5.4over 55NA4,536462P
Nan (24)2008MNCDSMauritius8.2Both
    Men6.6411001,941337H
    Women5.04202,318379H
Kramer (25)2009UCU.S.13.0Measure5.7634156655H
  • *Measure = using blood measurements, report = using reports by participants or physicians, and both = using both blood measurements and reports by participants or physicians.

  • †Number of participants included in the analysis in each study (not necessarily the number of participants at the beginning of each study). BRHS, British Regional Heart Study; CSCCC, Chin-Shan Community Cardiovascular Center; H, historical cohort; IIHDS, Israel Ischemic Heart Disease Study; JAPF, Japan Arteriosclerosis Prevention Fund; KS, The Kinmen Study; MNCDS, Mauritius Non-Communicable Diseases Surveys; MONIKA, MONIKA-Augsberg Cohort Study; NA, not available; OHS, The Osaka Health Study; P, prospective cohort; RS, The Rotterdam Study; SMB, The Study of Men Born in 1913; UC, University of California.